在试验性模型中,评估由卡巴马西平基纳米疗法诱导的心脏结构变化
Adem Tokpınar1, Hasan İlhan2, Semih Tan3
1Department of Anatomy, Faculty of Medicine, Ordu University, Ordu 52000, Türkiye.
Nanomaterials (Basel, Switzerland)
|November 26, 2025
概括
诱导的 (PTZ) 引起了老鼠的心脏损伤,但治疗卡巴马泽 (CBZ) 纳米颗粒在很大程度上保留了心脏组织结构. 这项研究探讨了潜在的治疗应用的新型纳米粒子涂层.
科学领域:
- 心血管研究研究心血管研究
- 神经科学是一个神经科学.
- 纳米医学是一种纳米医学.
背景情况:
- 实验性模型对于理解神经系统疾病至关重要.
- 卡巴马泽 (CBZ) 是一种抗药,具有潜在的心脏副作用.
- 纳米粒子药物递送系统提供了新的治疗策略.
研究的目的:
- 在试验性的老鼠中,研究CBZ涂层的碳纳米颗粒与银纳米颗粒 (CNDs@AgNPs) 和金属有机框架 (MOF-5) 纳米颗粒功能化的心脏形态效应.
- 为了评估心脏组织的组织病理和生化变化.
- 评估这些纳米粒子药物联体对引起的心脏毒性的保护潜力.
主要方法:
- 七十只雄性Wistar大鼠使用烯二 (PTZ) 诱导实验性.
- 动物被分为十组,接受不同的治疗,包括CBZ,CNDs@AgNPs和CNDs@MOF-5.
- 心脏组织使用血素-素染色进行了分析,并通过生物化学方法确定了白血素-6 (IL-6),催化酶 (CAT) 和氧化应激指数 (OSI) 的水平.
主要成果:
- PTZ诱导的导致了显著的组织病理学变化,包括心脏组织中的皮克诺斯核和出血区域.
- 在用CBZ涂层纳米颗粒治疗的组中,心脏组织结构在很大程度上得到保存.
- 特定的纳米粒子配方显示了心脏形态测量的变化,例如心房距离和顶部至底部的长度.
结论:
- PTZ诱导的会导致显著的心脏组织病理学变化.
- 涂有CNDs@AgNPs和CNDs@MOF-5纳米颗粒的卡巴马泽表明对心脏组织结构有保护作用.
- 这项研究在试验性模型中提出了纳米粒子药物合物的心脏保护潜力的新发现.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.6K
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
26.8K
相关概念视频
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
01:20Antiepileptic Drugs: Potassium Channel Activators
613
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
613